Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,063 | 175,250 | 113,253 | 260,487 | 150,738 |
| Marketable Securities | 269,017 | 245,948 | 335,704 | 173,262 | 202,413 |
| Receivables | 15,048 | 14,333 | 24,806 | 26,544 | 70,242 |
| TOTAL | $366,926 | $442,489 | $481,627 | $469,478 | $428,000 |
| Non-Current Assets | |||||
| PPE Net | 29,916 | 29,948 | 23,905 | 21,397 | 20,847 |
| Investments And Advances | 37,222 | 4,292 | 10,279 | 0 | 0 |
| Intangibles | 4,036 | 4,324 | 4,613 | 4,901 | 5,189 |
| Other Non-Current Assets | 21,331 | 21,489 | 20,382 | 23,638 | 23,701 |
| TOTAL | $92,505 | $60,053 | $59,179 | $49,936 | $49,737 |
| Total Assets | $459,431 | $502,542 | $540,806 | $519,414 | $477,737 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,714 | 26,540 | 32,412 | 34,265 | 36,527 |
| Accrued Expenses | 20,528 | 25,152 | 30,924 | 23,037 | 26,866 |
| Other current liabilities | 379 | 80 | 26 | 0 | 11 |
| TOTAL | $44,487 | $106,259 | $118,056 | $114,486 | $70,676 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,866 | 54,487 | 54,694 | 57,184 | 7,272 |
| Other Non-Current Liabilities | 10,039 | 5,924 | 5,128 | 4,960 | 3,793 |
| TOTAL | $40,790 | $35,769 | $35,889 | $34,613 | $35,153 |
| Total Liabilities | $85,277 | $142,028 | $153,945 | $149,099 | $105,829 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 76,858 | 76,387 | 76,231 | 74,198 | 71,853 |
| Common Shares | 8 | 8 | 8 | 7 | N/A |
| Retained earnings | -562,254 | -576,013 | -542,825 | -505,917 | -473,375 |
| Other shareholders' equity | -254 | -67 | -119 | -94 | -21 |
| TOTAL | $374,154 | $360,514 | $386,861 | $370,315 | $371,908 |
| Total Liabilities And Equity | $459,431 | $502,542 | $540,806 | $519,414 | $477,737 |